ARCHIVES

Inspector General’s chronology Of Events In Gallo Research

This article is from The Cancer Letter archive.

Vol. 20 No. 26 | July 1, 1994

Download PDF Visit The Full Archive

Related Articles

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

ACS’ Freeman: Declare New War On Cancer; Poor Get Substandard Treatment, Lose Dignity

July 21, 1989

DCBD Concepts Approved

November 8, 1985

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

Preventive Ovarian Surgery Recommended For Women with BRCA1 Mutations by Age 35

February 28, 2014